BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 19100166)

  • 1. [Advances in the diagnosis and treatment of yeast infections: role of the new antifungal agents].
    Pemán J; Almirante B
    Enferm Infecc Microbiol Clin; 2008 Nov; 26 Suppl 13():38-46. PubMed ID: 19100166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Advances and limitations in the early diagnosis of invasive yeast infections].
    Pontón J; del Palacio A
    Rev Iberoam Micol; 2007 Sep; 24(3):181-6. PubMed ID: 17874854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Role of anidulafungin in critically ill patients].
    Borges Sá M; Garnacho Montero J
    Enferm Infecc Microbiol Clin; 2008 Dec; 26 Suppl 14():35-43. PubMed ID: 19572433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Echinocandins in invasive candidiasis].
    Glöckner A; Cornely OA
    Med Klin (Munich); 2008 Jun; 103(6):397-405. PubMed ID: 18548209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Candida and candidaemia. Susceptibility and epidemiology.
    Arendrup MC
    Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Candida endophthalmitis: focus on current and future antifungal treatment options.
    Khan FA; Slain D; Khakoo RA
    Pharmacotherapy; 2007 Dec; 27(12):1711-21. PubMed ID: 18041891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Current status of invasive fungal infections. New diagnostic techniques and antifungal agents].
    Gurguí M; Cuenca-Estrella M
    Enferm Infecc Microbiol Clin; 2008 Dec; 26 Suppl 14():1-6. PubMed ID: 19572428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Therapy of candidemia and invasive candidiasis according to guidelines].
    Glöckner A
    Mycoses; 2010 May; 53 Suppl 1():30-5. PubMed ID: 20433654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Candidemia in the critically ill patient.
    Picazo JJ; González-Romo F; Candel FJ
    Int J Antimicrob Agents; 2008 Nov; 32 Suppl 2():S83-5. PubMed ID: 19013345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry.
    Horn DL; Neofytos D; Anaissie EJ; Fishman JA; Steinbach WJ; Olyaei AJ; Marr KA; Pfaller MA; Chang CH; Webster KM
    Clin Infect Dis; 2009 Jun; 48(12):1695-703. PubMed ID: 19441981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic potential of (1,3)-beta-D-glucan and anti-Candida albicans germ tube antibodies for the diagnosis and therapeutic monitoring of invasive candidiasis in neutropenic adult patients.
    Pazos C; Moragues MD; Quindós G; Pontón J; del Palacio A
    Rev Iberoam Micol; 2006 Dec; 23(4):209-15. PubMed ID: 17388644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Therapeutic efficacy of anidulafungin for the treatment of oesophageal candidiasis, candidemia and invasive candidiasis].
    Montejo González JC; Catalán González M; León Gil C
    Rev Iberoam Micol; 2008 Jun; 25(2):107-18. PubMed ID: 18473505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antifungal therapy update: new drugs and medical uses].
    Fortún J
    Enferm Infecc Microbiol Clin; 2011 Dec; 29 Suppl 5():38-44. PubMed ID: 22305668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Current treatment of candidemia. Role of anidulafungin].
    Almirante B; Pemán J
    Enferm Infecc Microbiol Clin; 2008 Dec; 26 Suppl 14():21-8. PubMed ID: 19572431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of caspofungin in invasive candidiasis and candidemia--de-escalation strategy.
    Lichtenstern C; Nguyen TH; Schemmer P; Hoppe-Tichy T; Weigand MA
    Mycoses; 2008; 51 Suppl 1():35-46. PubMed ID: 18471160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination antifungal therapy: where are we now, and where are we going?
    Marr K
    Oncology (Williston Park); 2004 Nov; 18(13 Suppl 7):24-9. PubMed ID: 15651179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential of anti-Candida antibodies in immunoprophylaxis.
    Cabezas J; Albaina O; Montañez D; Sevilla MJ; Moragues MD; Pontón J
    Immunotherapy; 2010 Mar; 2(2):171-83. PubMed ID: 20635926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antifungals in the ICU.
    Playford EG; Eggimann P; Calandra T
    Curr Opin Infect Dis; 2008 Dec; 21(6):610-9. PubMed ID: 18978529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Invasive fungal infections in the intensive care unit.
    Vazquez JA
    Semin Respir Crit Care Med; 2010 Feb; 31(1):79-86. PubMed ID: 20101550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Candida antigen and antibody kinetics during antifungal therapy in non-neutropenic intensive care patients].
    Wauer HJ; West C; Tietz HJ; Kox WJ
    Mycoses; 2000; 43 Suppl 2():57-61. PubMed ID: 11291579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.